With our ABCR® technology platform, we are developing solutions that revolutionize intraoperative blood transfusion and open new possibilities for immunosuppressed patients.
Today, we are on the verge of CE certification for our first product, CATUVAB®, while continuously expanding our portfolio of indications to meet critical patient needs worldwide.
The management of LBC is backed by an international high class and experienced Scientific Advisory Board.
Neil Blumberg, MD, is Professor of the Department of Pathology and Laboratory Medicine at the University of Rochester Medical Center and Director of the Transfusion Medicine Unit, Blood Bank, and Stem Cell Storage Facility.
Dr. Ulrich Granzer, PhD, CEO Granzer Regulatory Consultants, Munich, Germany, has been operating a leading consultancy for regulatory affairs and clinical development in Munich since 2002.
Professor Hartmut Link, MD, PhD, Professor of Medicine, is Managing Director of Onkodin GmbH, which develops and publishes digitized oncology treatment regimes, he works also in his Private Practice for Internal Medicine, Hematology & Oncology Kaiserslautern.
Professor Aryeh Shander, MD, FCCM, FCCP, FASA, is Clinical Professor of Anesthesiology, Medicine and Surgery at Icahn School of Medicine at Mount Sinai; Chief of Department of Anesthesiology, Critical Care Medicine, …
